Cure My Disease

Don't miss your cure!

 Log in / Sign up

Timing is everything: new study aims to reduce transplant complications

NCT ID NCT07047456

Recruiting now Disease control Sponsor: Anhui Provincial Hospital Source: ClinicalTrials.gov ↗

First seen Jan 05, 2026 · Last updated May 12, 2026 · Updated 20 times

Summary

This study looks at whether changing when stem cells are given during a cord blood transplant can lower the chance of a serious complication called graft-versus-host disease (GVHD). About 134 people with blood cancers who need a transplant will take part. The goal is to find a better way to time the infusion to improve safety and outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE GRAFT-VERSUS-HOST DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital

    RECRUITING

    Hefei, Anhui, 230001, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ACUTE GRAFT-VERSUS-HOST DISEASE